Literature DB >> 20337749

Flying vaccinator; a transgenic mosquito delivers a Leishmania vaccine via blood feeding.

D S Yamamoto1, H Nagumo, S Yoshida.   

Abstract

'Flying vaccinator' is the concept of using genetically engineered hematophagous insects to deliver vaccines. Here we show the generation of a transgenic anopheline mosquito that expresses the Leishmania vaccine candidate, SP15, fused to monomeric red fluorescent protein (mDsRed) in its salivary glands. Importantly, mice bitten repeatedly by the transgenic mosquitoes raised anti-SP15 antibodies, indicating delivery of SP15 via blood feeding with its immunogenicity intact. Thus, this technology makes possible the generation of transgenic mosquitoes that match the original concept of a 'flying vaccinator'. However, medical safety issues and concerns about informed consent mitigate the use of the 'flying vaccinator' as a method to deliver vaccines. We propose that this expression system could be applied to elucidate saliva-malaria sporozoite interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20337749     DOI: 10.1111/j.1365-2583.2010.01000.x

Source DB:  PubMed          Journal:  Insect Mol Biol        ISSN: 0962-1075            Impact factor:   3.585


  8 in total

1.  The crystal structure of the active domain of Anopheles anti-platelet protein, a powerful anti-coagulant, in complex with an antibody.

Authors:  Kanako Sugiyama; Mitsuhiro Iyori; Asuka Sawaguchi; Satoko Akashi; Jeremy R H Tame; Sam-Yong Park; Shigeto Yoshida
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

2.  Ethical issues in field trials of genetically modified disease-resistant mosquitoes.

Authors:  David B Resnik
Journal:  Dev World Bioeth       Date:  2012-12-21       Impact factor: 2.294

Review 3.  Peptides to Tackle Leishmaniasis: Current Status and Future Directions.

Authors:  Alberto A Robles-Loaiza; Edgar A Pinos-Tamayo; Bruno Mendes; Cátia Teixeira; Cláudia Alves; Paula Gomes; José R Almeida
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 4.  Genetically modified organisms and visceral leishmaniasis.

Authors:  Rudra Chhajer; Nahid Ali
Journal:  Front Immunol       Date:  2014-05-14       Impact factor: 7.561

5.  Inhibition of Malaria Infection in Transgenic Anopheline Mosquitoes Lacking Salivary Gland Cells.

Authors:  Daisuke S Yamamoto; Megumi Sumitani; Katsumi Kasashima; Hideki Sezutsu; Hiroyuki Matsuoka
Journal:  PLoS Pathog       Date:  2016-09-06       Impact factor: 6.823

6.  Experimental Implantation Trials of Xenopsylla cunicularis Smit (Siphonaptera: Pulicidae) in Northern France with the Objective to Use it as Vaccine Vector.

Authors:  Anne Darries-Vallier; Aurélien Ausset; Pierre Besrest
Journal:  Int J Insect Sci       Date:  2013-09-08

7.  One Injection of DsRed Followed by Bites from Transgenic Mosquitoes Producing DsRed in the Saliva Elicits a High Titer of Antibody in Mice.

Authors:  Hiroyuki Matsuoka; Gen-Ichiro Sano; Ryuta Hattori; Hiroyuki Tomita; Daisuke S Yamamoto; Makoto Hirai
Journal:  Trop Med Health       Date:  2012-08-04

8.  Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis.

Authors:  Jan Medlock; Katherine E Atkins; David N Thomas; Serap Aksoy; Alison P Galvani
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.